esophageal squamous cell carcinoma by ajcc v8 stage

Showing 1 - 4 of 4

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Esophageal Cancer, Esophageal Squamous Cell Carcinoma, Esophageal Squamous Cell Carcinoma by AJCC V8 Stage Trial (LBL-007,

Not yet recruiting
  • Esophageal Cancer
  • +2 more
  • (no location specified)
Aug 21, 2023

Esophageal Squamous Cell Carcinoma by AJCC V8 Stage Trial (Radiotherapy, Toripalimab)

Not yet recruiting
  • Esophageal Squamous Cell Carcinoma by AJCC V8 Stage
  • (no location specified)
Mar 17, 2023

Esophageal Squamous Cell Carcinoma by AJCC V8 Stage, Unresectable Trial in Tianjin (tislelizumab+ Paclitaxel + Cisplatin)

Recruiting
  • Esophageal Squamous Cell Carcinoma by AJCC V8 Stage
  • Unresectable
  • tislelizumab+ Paclitaxel + Cisplatin
  • Tianjin, Tianjin, China
    Hongjing Jiang
Jul 7, 2022

Esophageal Squamous Cell Carcinoma by AJCC V8 Stage, Resectable Esophageal Cancer Trial in Guangzhou (drug, radiation,

Unknown status
  • Esophageal Squamous Cell Carcinoma by AJCC V8 Stage
  • Resectable Esophageal Cancer
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Dec 22, 2019